Beta Bionics, Inc. Common Stock Financial Flexibility Index
Beta Bionics, Inc. Common Stock financial flexibility index. Beta Bionics, Inc. Common Stock (BBNX) has a Financial Flexibility Index of -0.38x as of June 2026. Free cash flow of $-13.58 Million (operating CF $-14.62 Million minus capex $1.04 Million) represents 0% of total liabilities ($36.02 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beta Bionics, Inc. Common Stock (2022–2025)
Financial flexibility index of Beta Bionics, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for Beta Bionics, Inc. Common Stock across 4 annual periods. Explore BBNX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Beta Bionics, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
Beta Bionics, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Beta Bionics, Inc. Common Stock. For the full cash flow conversion analysis, see Beta Bionics, Inc. Common Stock (BBNX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.11x | $-45.63 Million | $-50.92 Million | $41.13 Million | ▼ -82.0% |
| 2024 | -0.61x | $-44.88 Million | $-48.27 Million | $73.63 Million | ▲ +2.2% |
| 2023 | -0.62x | $-32.04 Million | $-32.45 Million | $51.43 Million | ▼ -115.5% |
| 2022 | -0.29x | $-59.44 Million | $-60.21 Million | $205.56 Million | — |